Omeprazole dosage forms
Pro Research Analysisby 
Searched over 200M research papers
Omeprazole Dosage Forms: Solid, Liquid, and Combination Formulations
Solid Dosage Forms: Capsules, Tablets, and Enteric-Coated Granules
Omeprazole is most commonly available as solid oral dosage forms, including capsules, tablets, and enteric-coated granules. These forms are designed to protect the acid-labile drug from degradation in the stomach's acidic environment and ensure its release in the more neutral pH of the small intestine. Enteric-coated capsules and tablets are widely used and have been shown to provide effective protection and controlled release of omeprazole, with dissolution and bioequivalence criteria established for generic formulations Agapakis2024Serebrova2024Yang2024. The enteric coating is essential for maintaining drug stability and bioavailability, as omeprazole degrades rapidly in acidic conditions Agapakis2024Serebrova2024Yang2024.
Liquid Dosage Forms: Suspensions and Syrups
For patients who have difficulty swallowing solid forms, such as children, the elderly, or critically ill individuals, liquid dosage forms are necessary. Traditionally, omeprazole suspensions are compounded extemporaneously from solid dosage forms by pharmacists, often using sodium bicarbonate as a buffering agent to enhance stability and prevent degradation in acidic environments Meissner2020Karami2015Adamiak-Giera2025+1 MORE. Studies have shown that suspensions prepared from certain brands of omeprazole capsules (e.g., Losec and Dr. Reddy's) maintain acceptable quality and stability for up to 20–30 days when stored at 4°C and protected from light . The inclusion of sodium bicarbonate in the formulation significantly improves omeprazole stability and drug recovery in liquid suspensions .
Recent advancements have led to the development of delayed-release liquid oral dosage forms, such as multi-layered particles suspended in syrup. These formulations use specialized polymers to prevent early drug release in the stomach and ensure targeted enteric release, offering similar performance to marketed enteric solid forms and providing a more convenient option for patients with swallowing difficulties .
Comparative Effectiveness and Pharmacokinetics
Comparative studies in pediatric patients have demonstrated that omeprazole suspensions can achieve similar blood levels and therapeutic effects as granule formulations, making them a suitable alternative for children who cannot swallow capsules or tablets . The stability and uniformity of compounded suspensions, however, depend on the source and quality of the original solid dosage form, as well as the compounding method Meissner2020Adamiak-Giera2025.
Novel and Combination Dosage Forms
Innovative approaches include the development of non-enteric coated oral dosage forms using semipermeable membranes, which may offer alternative release profiles for omeprazole and its enantiomer, S-omeprazole . Additionally, combination dosage forms, such as bilayer tablets containing both aspirin and omeprazole, are being explored to improve patient compliance and reduce gastrointestinal side effects in patients requiring both medications. Surveys indicate strong preference among patients and healthcare providers for such combination products, especially at standard doses (e.g., 20 mg omeprazole) .
Conclusion
Omeprazole is available in a variety of dosage forms to meet diverse patient needs. Solid enteric-coated capsules and tablets remain the standard, but liquid suspensions—especially those compounded with sodium bicarbonate—are essential for populations with swallowing difficulties. Newer technologies, such as delayed-release syrups and combination tablets, are expanding the options for omeprazole administration, aiming to improve patient compliance, stability, and therapeutic outcomes Ronchi2019Meissner2020Serebrova2024+4 MORE.
Sources and full results
Most relevant research papers on this topic